NOTE 9 – Loss Per Share

The following data show the amounts used in computing loss per share and the effect on income and the weighted average number of shares of dilutive potential common stock for the periods ended December 31, 2019 and 2018:

Dilutive loss per share was not presented as the Company’s outstanding warrants, stock options and note conversion features common equivalent shares for the periods presented would have had an anti-dilutive effect. At December 31, 2019, the Company had outstanding 363,727 warrants which could be converted to 363,727 shares of common stock, a $50,000 note payable convertible into 2,500 shares of common stock, and 180,903 stock options exercisable for 180,903 shares of common stock resulting in a potential total additional 475,130 common stock shares outstanding in the future. At December 31, 2018, the Company had outstanding 305,050 warrants which could be converted to 305,060 shares of common stock, a $50,000 note payable convertible into 2,500 shares of common stock, and 82,627 stock options exercisable for 82,627 shares of common stock resulting in a potential total additional 390,187 common stock shares outstanding in the future.